Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Epidemiology, Clinical Features, and Molecular Basis of TTMV::RARA-driven Acute Promyelocytic Leukemia

Xiaosu Zhou, Jiaqi Chen, Yan‑Lai Tang, Haibo Sun, Qihui Chen, Xue Chen, Yang Zhang, Jiancheng Fang, Panxiang Cao, Xiaoli Ma, Li Chen, Yangyang Xie, Lijun Wen, Li-Bin Huang, Zhong Fan, Jiacheng Lou, Wenning Xu, Nan Zhang, Jing Li, Yu Luo, Yan Dai, Huan Du, Kun Yang, Zhixu He, Xiaoyan Yang, Linya Wang, Bing Liu, Danna Lin, Yajie Zhang, Fang Xu, Min Zhang, Yang Wang, Shu Yan, Hua Nan, Jing Zhang, Li Xu, Xiujuan Ma, Ruijie Tang, Fang Wang, Lili Yuan, Ming Liu, Lei Wang, Qisheng Wu, Lina Zhang, Siyuan Liu, Chengcheng Yan, Jianfeng Zhou, Fanyong Lyu, Ping Wu, Tong Wang, Xian Zhang, Yue Lu, Deyan Liu, Junfang Yang, Min Xiong, Yanli Zhao, Gaowei Fan, Xia Xiao, Futian Ma, Lihua Yang, Xue-Qun Luo, Jun-Min Li, Shuhong Shen, Huyong Zheng, Suning chen, Hongwei Chen, Jianhong Zhao, Zhanglin Zhang, KanKan Wang, Prof., Peihua Lu, Hongxing Liu

Blood blood.2025028674.

https://doi.org/10.1182/blood.2025028674

Published: 2025

Includes: Supplemental data

Journal Articles

Quality of Life after Gene Therapy in Pediatric Patients with Transfusion-Dependent β-Thalassemia and Their Family Caregivers: A Prospective Cohort Study

Zhexiang Kuang, Anni Wang, Xiao Yu, Jing Xu, Weiwei Wang, Chun Xu, Xintong He, Weiping Yuan, Jun Shi, Li Xu, Wenjun Xie

Blood (2024) 144 (Supplement 1): 7653.

https://doi.org/10.1182/blood-2024-200445

Published: 2024

Journal Articles

Patient Journey Mapping Enhances Nursing Care in Patients with Hematologic Diseases

Zhexiang Kuang, Xiao Yu, Anni Wang, Jing Xu, Jingyu Zhao, Xinli Li, Guibin Wu, Weiping Yuan, Jun Shi, Li Xu, Wenjun Xie

Blood (2024) 144 (Supplement 1): 7555.

https://doi.org/10.1182/blood-2024-200424

Published: 2024

Journal Articles

Successful 24-Hours Manufacture of Anti-CD19/CD22 Dual Chimeric Antigen Receptor (CAR) T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Junfang Yang, Pengfei Jiang, Xian Zhang, MD, Jingjing Li, Yan Wu, Li Xu, Yunchao Su, Xiaona Hu, Xiaoyan Zhao, Qi Dong, Songbai Cai, Zhenguang Wang, Yuezhang Chen, Xun Ye, Jiaping He, Nanjing Lin, Wei Cao, Martina Sersch, MD PhD, Peihua Lu, MD

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-136866

Published: 2020

Journal Articles

Feasibility, and Efficacy of Donor-Derived cd19-Targeted Car t-Cell Therapy in Refractory/Relapsed(r/r)b-Cell Acute Lymphoblastic Leukemia (b-all) Patients

Xian Zhang, MD, Junfang Yang, Wenqian Li, Gailing Zhang, MD, Yunchao Su, Yanze Shi, Dan Song, Min Zhang, Jiujiang He, Li Xu, Liyuan Qiu, Xin-An Lu, Fei Wu, Jianqiang Li, PhD, Dandan Chen, Xiangqun Li, Ziyu Li, Jingjing Li, Peihua Lu, MD

Blood (2020) 136 (Supplement 1): 4–6.

https://doi.org/10.1182/blood-2020-137299

Published: 2020

Journal Articles

Factors Predicting Long-Term Survival Following CD19 CAR T-Cell Therapy in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Xian Zhang, MD, Junfang Yang, Wenqian Li, Gailing Zhang, MD, Yunchao Su, Yanze Shi, Dan Song, Min Zhang, Jiujiang He, Li Xu, Jingjing Li, Xinan Lu, Jianqiang Li, PhD, Xiangqun Li, Zhongwei Xu, Ziyu Li, Peihua Lu, MD

Blood (2020) 136 (Supplement 1): 1–2.

https://doi.org/10.1182/blood-2020-136897

Published: 2020

Journal Articles

A Feasibility and Safety Study of a New CD19-Directed Fast CAR-T Therapy for Refractory and Relapsed B Cell Acute Lymphoblastic Leukemia

Blood (2019) 134 (Supplement_1): 825.

https://doi.org/10.1182/blood-2019-121751

Published: 2019

Journal Articles

A Multi-Center Epidemiological and Prognostic Analysis of Cytogenetic Abnormalities in a Cohort of 1015 Chinese Patients with Newly-Diagnosed Multiple Myeloma

Fengyan Jin, MD PhD, Guangxun Gao, MD, Yujun Dong, MD, Chunrui Li, MD PhD, Wenrong Huang, Limo Zhang, MD, Qiang Zhu, MD, Ruifeng Yuan, MD, Li Xu, MD, Yanjie Xu, MD, Qian Xu, Shaji K. Kumar, MD, Yun Dai, MD

Blood (2019) 134 (Supplement_1): 3094.

https://doi.org/10.1182/blood-2019-132076

Published: 2019

Journal Articles

Anti-CD19/CD22 Dual CAR-T Therapy for Refractory and Relapsed B-Cell Acute Lymphoblastic Leukemia

Junfang Yang, MD, Pengfei Jiang, Xian Zhang, MD, Xiaobin Zhu, Qi Dong, Jiaping He, Nanjing Lin, Zhenguang Wang, Songbai Cai, Xun Ye, Yunchao Su, Wenqian Li, Jingjing Li, Ziyao Yu, Jiujiang He, Li Xu, Dan Song, Wei Cao, Peihua Lu

Blood (2019) 134 (Supplement_1): 284.

https://doi.org/10.1182/blood-2019-126429

Published: 2019

Journal Articles

Combined Low-Dose Homoharringtonine, Cytarabine and Granulocyte Colony-Stimulating Factor for Patients with Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia Transformed From MDS

Lingyun Wu, Xiao Li, MD, PhD, Chunkang Chang, Jiying Shu, Li Xu, Zheng Zhang

Blood (2010) 116 (21): 4004.

https://doi.org/10.1182/blood.V116.21.4004.4004

Published: 2010

Journal Articles

Appropriate Timing of G-CSF Use After Mobilization Chemotherapy Significantly Increases the Yield ofCD34+ Cells in autoPBSCT.

Li Xu, Chunkang Chang, Xiao Li, MD, PhD

Blood (2009) 114 (22): 2144.

https://doi.org/10.1182/blood.V114.22.2144.2144

Published: 2009

Journal Articles

The Incidence of Corrected Hypercalcemia and Its Relationship with Prognosis for Chinese Multiply Myeloma.

Xi Zhang, Chunkang Chang, Xiao Li, MD, PhD, Jiying Su, Lingyun Wu, MD, Liyu Zhou, Qi He, Li Xu, Luxi Song, Quan Pu

Blood (2009) 114 (22): 4903.

https://doi.org/10.1182/blood.V114.22.4903.4903

Published: 2009

Journal Articles

Autoimmune Thrombocytopenic Purpura in a Patient with Renal Clear Cell Carcinoma

Li Xu, Shaoxu Ying, Xiao Li, MD, PhD

Blood (2008) 112 (11): 4572.

https://doi.org/10.1182/blood.V112.11.4572.4572

Published: 2008

Journal Articles

Rituximab-Relapsing Patients with Non-Hodgkins Lymphoma Respond Even at Lower Doses of Humanized Anti-CD20 Antibody, IMMU-106 ( hA 20): Phase I/II Results.

Franck Morschhauser, MD, John P. Leonard, MD, Luis Fayad, MD, Bertrand Coiffier, MD, STephen J. Schuster, MD, Martin J.S. Dyer, MD, Marie-Odile Petillon, MD, Morton Coleman, MD, Amina Bahkti, Heather Horne, Li Xu, MD, Nick Teoh, PhD, William A. Wegener, MD, David M. Goldenberg, MD

Blood (2006) 108 (11): 2719.

https://doi.org/10.1182/blood.V108.11.2719.2719

Published: 2006

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Epidemiology, Clinical Features, and Molecular Basis of TTMV::RARA-driven Acute Promyelocytic Leukemia

Quality of Life after Gene Therapy in Pediatric Patients with Transfusion-Dependent β-Thalassemia and Their Family Caregivers: A Prospective Cohort Study

Patient Journey Mapping Enhances Nursing Care in Patients with Hematologic Diseases

Successful 24-Hours Manufacture of Anti-CD19/CD22 Dual Chimeric Antigen Receptor (CAR) T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Feasibility, and Efficacy of Donor-Derived cd19-Targeted Car t-Cell Therapy in Refractory/Relapsed(r/r)b-Cell Acute Lymphoblastic Leukemia (b-all) Patients

Factors Predicting Long-Term Survival Following CD19 CAR T-Cell Therapy in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

A Feasibility and Safety Study of a New CD19-Directed Fast CAR-T Therapy for Refractory and Relapsed B Cell Acute Lymphoblastic Leukemia

A Multi-Center Epidemiological and Prognostic Analysis of Cytogenetic Abnormalities in a Cohort of 1015 Chinese Patients with Newly-Diagnosed Multiple Myeloma

Anti-CD19/CD22 Dual CAR-T Therapy for Refractory and Relapsed B-Cell Acute Lymphoblastic Leukemia

Combined Low-Dose Homoharringtonine, Cytarabine and Granulocyte Colony-Stimulating Factor for Patients with Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia Transformed From MDS

Appropriate Timing of G-CSF Use After Mobilization Chemotherapy Significantly Increases the Yield ofCD34+ Cells in autoPBSCT.

The Incidence of Corrected Hypercalcemia and Its Relationship with Prognosis for Chinese Multiply Myeloma.

Autoimmune Thrombocytopenic Purpura in a Patient with Renal Clear Cell Carcinoma

Rituximab-Relapsing Patients with Non-Hodgkins Lymphoma Respond Even at Lower Doses of Humanized Anti-CD20 Antibody, IMMU-106 ( hA 20): Phase I/II Results.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only